Lungenpraxis Niendorf
- Address
- Paul-Sorge-Strasse 22, 22459 Hamburg, Germany
Lungenpraxis Niendorf - Respiratory Medicine Research Center
Lungenpraxis Niendorf is a specialized pulmonary medicine research center dedicated to advancing the treatment and management of chronic respiratory diseases. The center focuses on investigating innovative therapeutic approaches and optimizing treatment strategies for patients with complex lung conditions.
- Chronic Obstructive Pulmonary Disease (COPD) treatment optimization
- Comparative studies of bronchodilator and combination inhaler therapies
- Cardiopulmonary outcome research in respiratory disease
The center actively conducts clinical trials evaluating triple therapy combinations using medications such as budesonide, glycopyrronium, and formoterol fumarate delivered via metered-dose inhalers. Their research particularly emphasizes assessing the impact of advanced treatment regimens on severe cardiopulmonary outcomes, comparing the efficacy of combination therapies with dual bronchodilator approaches to improve patient quality of life and reduce disease complications in COPD populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Lungenpraxis Niendorf
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Budesonide, Glycopyrronium Bromide, and Formoterol Fumarate on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Patients | AstraZeneca AB | Phase III | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Budesonide | 1 | Unknown | 2024-07-04 | 2024-07-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.